# Boston Scientific Corporation (BSX) — Q1-2022 Earnings Results

**Report date:** 2022-04-27 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q1-2022

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Up 1.08%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.39 | N/A | +1.30% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their strategic direction despite not providing specific guidance. They emphasized their commitment to innovation and market expansion.

**Key quotes:**

> Management highlighted the resilience of their product portfolio.

> They noted ongoing investments in innovation to drive future growth.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Boston Scientific's earnings report shows a slight positive surprise on EPS, indicating better-than-expected profitability. The stock reacted positively, rising by 1.08%, likely driven by management's optimistic tone regarding their product portfolio and future growth strategies. However, the lack of revenue data and guidance leaves some uncertainty for investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q1-2022_